Some more vaccine news released from the FDA review of the Moderna data. In the Moderna study, they apparently swabbed all trial participants prior to their second dose and found that there was also a reduction in asymptomatic transmission by 64%.
This is a follow up on a couple posts I had with OSU and Hoosier last week regarding the Pfizer/Biontech study. That study looked at only symptomatic patients so it is possible the vaccines are only effective at preventing symptoms/reducing disease severity and not necessarily preventing infection. This new data from Moderna provides more evidence that the Moderna vaccine probably does both. Since the vaccines are both using the same technology, I think it's a safe assumption that both mRNA vaccines will provide similar benefits to the recipient.
And hopefully they are even more potent at preventing transmission after both doses because the finding was only after the first dose.
https://www.nbcnews.com/news/amp/ncna1251237?__twitter_impression=true